Jun 2025 Volume 6Number 6: Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial

https://www.thelancet.com/journals/lanmic/issue/vol6no6/PIIS2666-5247(25)X0006-9 Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00305-7/fulltext?dgcid=hubspot_update_feature_updatealerts_lanmic&utm_campaign=update-lanmic&utm_medium=email&_hsenc=p2ANqtz--yYlfoMRp1L-syNGH4NK5XRPACjobgovDpHtvdziXnwi0gJj66NSNCREMLP9W_eQJbbY32yp_Ts9_hkIFLcl3e3PiYsw&_hsmi=367196265&utm_content=366877333&utm_source=hs_email